The genetic depletion of BRD4 resulted in a stark decrease in tumour growth and improved survival when xenografted into mice [40], demonstrating the dependence of DIPG tumours on BRD4. The gene discussed is BRD4; the disease is diffuse intrinsic pontine glioma.